News / Health

    Could Existing Drugs Be Used to Treat Deadly MERS Virus?

    Can Existing Drugs Help Fight Deadly MERS Virus?i
    X
    Steve Baragona
    May 07, 2014 12:49 PM
    A deadly new illness has appeared in the Middle East, and doctors have no medicine to stop it. So far, Middle East Respiratory Syndrome does not spread easily from person to person. But it has killed roughly a quarter of those infected, and experts are watching it closely in case it becomes more contagious. In the scramble to find a cure, scientists are turning up some unexpected candidates. VOA’s Steve Baragona has more.
    A lethal new virus that originated in the Middle East is spreading and there is no drug to fight it.

    Or is there? Scientists are scouring the medicine cabinet for existing drugs to fight Middle East Respiratory Syndrome (MERS) and they're finding some unexpected candidates. 

    In lab studies, drugs against cancer, neurological disorders and other ailments show promise to help treat MERS. 

    Why would a cancer drug stop a virus? Scientists don’t necessarily know. But the fact that they work at all is helping researchers understand previously unknown ways in which the drugs -- and the viruses -- function.

    'Extraordinary' virus

    MERS has killed about a quarter of the roughly 500 people infected since it was first detected in 2012. 

    “The mortality rate is extraordinary,” said National Institute of Allergy and Infectious Diseases Director Anthony Fauci. “That’s unheard of with common respiratory infections. That’s the very, very sobering news about this. The somewhat encouraging news so far is that it is not readily spread from person to person.”
    Passengers walk past the medical quarantine area showing information sheets on Middle East respiratory syndrome (MERS) at the arrivals section of Manila's International Airport in Paranaque, south of Manila, April 16, 2014.Passengers walk past the medical quarantine area showing information sheets on Middle East respiratory syndrome (MERS) at the arrivals section of Manila's International Airport in Paranaque, south of Manila, April 16, 2014.
    The virus that causes MERS is related to the SARS virus that erupted out of China in 2003. SARS killed about 10 percent of its approximately 8,000 victims but it was much more contagious than MERS is. Experts are keeping a close eye on MERS in case it mutates to become more infectious. 

    Long wait for new drugs

    Doctors have little to offer MERS patients. There are no drugs approved by the U.S. Food and Drug Administration. 

    And developing a new drug is time-consuming and expensive. Virologist Matt Frieman at the University of Maryland at Baltimore says candidates that work well in a test tube often do not work in living cells. 

    “And the ones that do, when you now take them from a cell to an animal model of the disease, most of them don’t work,” he said. 

    Drugs that are effective in animal tests still need to go through three stages of clinical trials to be sure they help sick people without doing more harm than good.

    “Starting from scratch, to go from basic research in an academic lab to getting a product licensed by the FDA, can take a decade and tons and tons of money,” said immunologist Erik Stemmy, who oversees MERS research grants for the National Institute of Allergy and Infectious Diseases (NIAID).

    Robot testing

    That’s why NIAID is backing efforts to look for drugs that are already FDA-approved for something else that might also work against MERS.

    Robots are lending a hand. Automated systems developed in just the last few years can screen hundreds of drugs at a time.

    “You can do a lot of quick, test-tube, petri-dish screens to see if, hey, does this have any efficacy or not,” Stemmy said. “That’s what’s really moving this field forward.”

    Stemmy added that researchers are using the same techniques to hunt for existing drugs that fight antibiotic-resistant germs, another growing public health problem with little or nothing new in the drug-development pipeline.

    The robots have turned up about two dozen drugs that Frieman is putting through further tests. 

    “Most of them have not been used against viruses at all,” he said.
     


    It is not always clear how these drugs work, even for their intended purpose. Frieman says only recently did scientists begin designing medicines against specific parts of a cell’s machinery. Many started out as plant extracts or other compounds that treated a disease, even though doctors did not know why or how. 

    “A lot of these drugs do things that either were not known before,” he said, “or they target the things that everyone thought they targeted, but no one knew that that was involved in virus replication.”

    When a virus infects a cell, it hijacks the cell’s machinery to replicate, or make copies of itself. In pictures from one experiment, Frieman points out how one type of cellular protein important in infection is normally scattered around the cell, but moves to the center of the cell when treated with one drug.

    “We don’t know why they do this with the drug. But we know that the drug that does this inhibits replication of the virus.”

    'Promising candidates'

    These drugs still need to be tested to see if they work as well in animals as they do in a petri dish. Only then would they be considered for sick patients.

    But the fact that they are already FDA-approved is one less hurdle they need to clear.

    “I think that we have some definite promising therapeutic candidates in the pipeline,” Stemmy said. “And I think that if things progress with the infections and the spread, I think we’re in a really good position to be able to respond.”

    And what they are learning from MERS may put scientists in a good position to respond to other new viruses.

    Steve Baragona

    Steve Baragona is an award-winning multimedia journalist covering science, environment and health.

    He spent eight years in molecular biology and infectious disease research before deciding that writing about science was more fun than doing it. He graduated from the University of North Carolina at Chapel Hill with a master’s degree in journalism in 2002.

    You May Like

    In Britain, The Sun Still Doesn’t Shine

    Invoking Spitfires and Merlin, Leave voters insist country can be great again, following surprising 'Brexit' vote last week

    Double Wave of Suicide Bombings Puts Lebanon, Refugees on Edge

    Following suicide bombings in Christian town of Al-Qaa, on Lebanon's northeast border with Syria, fears of further bombings have risen

    US Senators Warned on Zika After Failing to Pass Funding

    Zika threats and challenges, as well as issues of contraception and vaccines, spelled out as lawmakers point fingers

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: rand moore from: SZ, China
    May 07, 2014 6:43 PM
    Since MERS is said to be related to SARS, maybe researchers should review what Hong Kong (and other SARs researchers) did to fight that disease, including what medicines they tried. There's a chance that what was effective in treating SARs patients could be effective against MERS.

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Slow Rebuilding Amid Boko Haram Destruction in Nigeria’s Northeasti
    X
    June 29, 2016 6:15 PM
    Military operations have chased Boko Haram out of towns and cities in Nigeria’s northeast since early last year. But it is only recently that people have begun returning to their homes in Adamawa state, near the border with Cameroon, to try to rebuild their lives. For VOA, Chris Stein traveled to the area and has this report.
    Video

    Video Slow Rebuilding Amid Boko Haram Destruction in Nigeria’s Northeast

    Military operations have chased Boko Haram out of towns and cities in Nigeria’s northeast since early last year. But it is only recently that people have begun returning to their homes in Adamawa state, near the border with Cameroon, to try to rebuild their lives. For VOA, Chris Stein traveled to the area and has this report.
    Video

    Video Clinton Leads Trump, But Many Voters Don't Like Either

    In the U.S. presidential race, most recent polls show Democrat Hillary Clinton with a steady lead over Republican Donald Trump as both presumptive party nominees prepare for their party conventions next month. Trump’s disapproval ratings have risen in some recent surveys, but Clinton also suffers from high negative ratings, suggesting both candidates have a lot of work to do to improve their images before the November election. VOA National correspondent Jim Malone has more from Washington.
    Video

    Video New US Ambassador to Somalia Faces Heavy Challenges

    The new U.S. envoy to Somalia, who was sworn into office Monday, will be the first American ambassador to that nation in 25 years. He will take up his post as Somalia faces a number of crucial issues, including insecurity, an upcoming election, and the potential closure of the Dadaab refugee camp in Kenya. VOA’s Jill Craig asked Somalis living in Kenya’s capital city Nairobi how they feel about the U.S. finally installing a new ambassador.
    Video

    Video At National Zoo, Captivating Animal Sculptures Illustrate Tragedy of Ocean Pollution

    The National Zoo in Washington, D.C., is home to about 1,800 animals, representing 300 species. But throughout the summer, visitors can also see other kinds of creatures there. They are larger-than-life animal sculptures that speak volumes about a global issue — the massive plastic pollution in our oceans. VOA's June Soh takes us to the zoo's special exhibit, called Washed Ashore: Art to Save the Sea.
    Video

    Video Baghdad Bikers Defy War with a Roar

    Baghdad is a city of contradictions. War is a constant. Explosions and kidnappings are part of daily life. But the Iraqi capital remains a thriving city, even if a little beat up. VOA's Sharon Behn reports on how some in Baghdad are defying the stereotype of a nation at war by pursuing a lifestyle known for its iconic symbols of rebellion: motorbikes, leather jackets and roaring engines.
    Video

    Video Melting Pot of Immigrants Working to Restore US Capitol Dome

    The American Iron Works company is one of the firms working to renovate the iconic U.S. Capitol Dome. The company employs immigrants of many different cultural and national backgrounds. VOA’s Arman Tarjimanyan has more.
    Video

    Video Testing Bamboo as Building Material

    For thousands of years various species of bamboo - one of the world's most versatile plants - have been used for diverse purposes ranging from food and medicine to textiles and construction. But its use on a large scale is hampered because it's not manufactured to specific standards but grown in the ground. A University of Pittsburgh professor is on track to changing that. VOA’s George Putic reports.
    Video

    Video Orphanage in Iraqi City Houses Kids Who Lost their Parents to Attacks by IS

    An orphanage in Iraqi Kurdistan has become home to scores of Yazidi children who lost their parents after Islamic State militants took over Sinjar in Iraq’s Nineveh Province in 2014. Iraqi Kurdish forces backed by the U.S. airstrikes have since recaptured Sinjar but the need for the care provided by the orphanage continues. VOA’s Kawa Omar filed this report narrated by Rob Raffaele.
    Video

    Video Re-Opening Old Wounds in a Bullet-Riddled Cultural Landmark

    A cultural landmark before Lebanon’s civil war transformed it into a nest of snipers, Beirut’s ‘Yellow House’ is once again set to play a crucial role in the city.  Built in a neo-Ottoman style in the 1920s, in September it is set to be re-opened as a ‘memory museum’ - its bullet-riddled walls and bunkered positions overlooking the city’s notorious ‘Green Line’ maintained for posterity. John Owens reports from Beirut.
    Video

    Video Brexit Resounds in US Presidential Contest

    Britain’s decision to leave the European Union is resounding in America’s presidential race. As VOA’s Michael Bowman reports, Republican presumptive nominee Donald Trump sees Britain’s move as an affirmation of his campaign’s core messages, while Democrat Hillary Clinton sees the episode as further evidence that Trump is unfit to be president.
    Video

    Video NASA Juno Spacecraft, Nearing Jupiter, to Shed Light on Gas Giant

    After a five-year journey, the spacecraft Juno is nearing its destination, the giant planet Jupiter, where it will enter orbit and start sending data back July 4th. As Mike O'Sullivan reports from Pasadena, California, the craft will pierce the veil of Jupiter's dense cloud cover to reveal its mysteries.
    Video

    Video Orlando Shooting Changes Debate on Gun Control

    It’s been nearly two weeks since the largest mass shooting ever in the United States. Despite public calls for tighter gun control laws, Congress is at an impasse. Democratic lawmakers resorted to a 1960s civil rights tactic to portray their frustration. VOA’s Carolyn Presutti explains how the Orlando, Florida shooting is changing the debate.

    Special Report

    Adrift The Invisible African Diaspora